For many small and mid-sized life sciences and medical device companies, an FDA inspection still feels like a quality or manufacturing event. Teams prepare documentation, review SOPs, organize training records, and make sure production processes are ready for review.
But today’s FDA inspections go much deeper than the production floor.
Investigators are increasingly looking at the systems, infrastructure, and controls that support your quality processes, product data, and operational records. That means IT is no longer sitting on the sidelines during an inspection. It is part of the conversation.
If your systems are unreliable, poorly secured, difficult to audit, or lacking proper controls, it can quickly become a compliance concern.
For growing organizations in regulated industries, this creates a difficult reality. Most companies do not have large internal IT teams or dedicated compliance technology staff. Yet they are still expected to maintain secure, traceable, and reliable systems that support FDA-regulated operations.
Here is what investigators are actually paying attention to and why IT has become a critical piece of inspection readiness.
Why IT Matters During an FDA Inspection
The FDA’s focus is ultimately about data integrity, patient safety, and process control.
Nearly every regulated process today relies on technology in some way. Quality systems, ERP platforms, document management systems, cloud applications, cybersecurity controls, backups, and user access policies all contribute to how reliable and trustworthy your data is.
If investigators cannot trust your systems, they may question the integrity of the records inside them.
That is why IT often becomes part of discussions around:
- Electronic records and signatures
- Data retention and traceability
- User access controls
- Audit trails
- Backup and disaster recovery
- System validation
- Cybersecurity protections
- Change management
- Vendor and third-party risk
For smaller manufacturers and regulated businesses, this is where gaps often appear.
Systems may have been implemented quickly. Processes may rely on tribal knowledge. Access permissions may not be reviewed consistently. Backup strategies may exist but not be regularly tested.
These issues may not seem urgent during day-to-day operations, but they can become highly visible during an FDA inspection.
What FDA Investigators Are Commonly Looking At
1. Data Integrity and Audit Trails
One of the biggest concerns during inspections is whether data can be trusted.
Investigators want to understand:
- Who accessed records
- What changes were made
- When changes occurred
- Whether modifications can be traced
- Whether records can be deleted or manipulated improperly
This is especially important for systems tied to quality management, manufacturing, testing, CAPAs, complaints, and clinical processes.
If audit trails are disabled, incomplete, or difficult to retrieve, it raises immediate concerns.
Common pain points for growing companies include:
- Shared user accounts
- Lack of role-based access
- No formal audit log review process
- Inconsistent documentation practices
- Legacy systems with limited visibility
2. Access Control and User Permissions
Investigators frequently evaluate whether employees only have access to the systems and data required for their role.
Questions often include:
- How are user accounts created?
- How are terminated employees removed?
- Who approves access changes?
- Are administrator privileges limited?
- How often are permissions reviewed?
This becomes especially important as organizations scale.
Many regulated companies grow quickly and accumulate years of permission changes without structured oversight. Over time, users may end up with excessive access, outdated credentials, or unnecessary administrative rights.
That creates both security and compliance risks.
3. Backup and Disaster Recovery Preparedness
FDA investigators may ask how your company protects critical systems and regulated records.
They want confidence that:
- Data can be recovered after an outage or ransomware attack
- Backups are secure and tested
- Business operations can continue during disruption
- Critical systems are recoverable within acceptable timeframes
This is an area where many smaller organizations struggle.
Backups may technically exist, but testing is inconsistent. Recovery timelines may be unclear. Cloud systems may create a false sense of security without clear ownership of backup responsibilities.
A successful backup strategy is not just about storing data. It is about proving you can restore operations reliably.
4. Cybersecurity Controls
Cybersecurity has become increasingly important in regulated industries because security incidents directly impact operational continuity and data integrity.
An investigator may not conduct a formal cybersecurity audit, but security weaknesses can quickly surface during discussions around systems and controls.
Common areas of concern include:
- Multi-factor authentication
- Endpoint protection
- Patch management
- Email security
- Network segmentation
- Remote access security
- Incident response planning
Medical device manufacturers and life sciences organizations are attractive targets because they often handle valuable intellectual property, sensitive data, and regulated operations while operating with lean internal resources.
Ransomware, phishing, and unauthorized access events can severely disrupt compliance-sensitive environments.
5. Vendor and Third-Party Oversight
Most growing organizations rely heavily on external vendors for cloud platforms, IT support, software hosting, and infrastructure management.
Investigators increasingly want to understand:
- Who manages your systems
- How vendors are evaluated
- Whether responsibilities are clearly defined
- How security and compliance expectations are maintained
This includes MSPs, cloud providers, software vendors, and outsourced technology partners.
If your IT environment is managed externally, your organization is still responsible for ensuring systems remain compliant, secure, and properly controlled.
More to Explore
More insights and resources worth checking out
More insights and resources worth checking out.
